Skila Releases Next Generation Global KOL Management Solution: iAdvocate 2.0

August 02, 2007 (PRLEAP.COM) Health News
Morris Plains, NJ, – Skila, A Sela2 Company, announces the release of its next generation Global Key Opinion Leader (KOL) Management Solution, iAdvocate 2.0 – with workflows designed based on the best practices of leading global pharmaceutical organizations.

A recognized leader in global thought leader management and strategy, Skila recognizes that global KOL management is more than just managing databases or information using an enterprise-wide software tool; it is a paradigm shift towards a unified, strategic and measurable approach for the entire KOL relationship management process that is built on common and compliant workflows of a global pharmaceutical organization. As such, Skila has incorporated the best practices of leading organizations to deliver an iAdvocate 2.0 solution with a workflow that focuses on the Six Core Tenets of KOL Relationship Management.

“Few companies have developed a process and capability well integrated enough to focus on the entire KOL relationship management process in a measurable way – especially on a global scale,” says Simon Mason, Chief Operating Officer at Skila. “This poses a major challenge as global organizations strive to create a coordinated and consistent approach across countries, business units, and functional areas,” continues Mason. “Effective management of relationships with world-wide, national, regional and even local KOLs is critical to the success of global pharmaceutical companies and brands. It necessitates working within varying regulatory environments, countries, business units and functional areas that require relevant KOL knowledge and expertise.”

About Skila

For over 13 years Skila has been recognized as a world-wide leader in delivering global brand effectiveness solutions and platforms to pharmaceutical and biotechnology companies world-wide. Skila’s solutions have helped facilitate over Ten Million user interactions in 56 countries across 11 therapeutic categories for more then 30 brands. Skila’s solutions foster multi-way communication and the sharing of best practices, while incorporating built-in actions and work-flows that reflect real-life work efforts, augment world-wide collaboration, and drive more coordinated management of global brand resources, assets and best practices. Skila’s full-service solutions help Pharmaceutical clients more effectively and proactively manage:
• The launch and lifecycle of global brands
• Local, national and global key opinion leaders
• Business performance of brands and franchises across the globe
• Global and local competitive intelligence
• The success of partnerships and alliances